P2-12-19: Nomogram To Predict Recurrence and To Avoid Unnecessary Adjuvant Chemotherapy Based on Ki67 Index and ER Status in Hormone Receptor (HR)-Positive Breast Cancers with Low Number of Nodal Metastases (≤3) (NCT01273415)

MLA

B Keam, et al. “P2-12-19: Nomogram To Predict Recurrence and To Avoid Unnecessary Adjuvant Chemotherapy Based on Ki67 Index and ER Status in Hormone Receptor (HR)-Positive Breast Cancers with Low Number of Nodal Metastases (≤3) (NCT01273415).” Cancer Research, vol. 71, Dec. 2011, pp. P2-12. EBSCOhost, https://doi.org/10.1158/0008-5472.sabcs11-p2-12-19.

APA

B Keam, Y-H Im, S-A Im, Young-Ae Park, SJ Nam, JH Yang, IH Park, D-Y Noh, Joonghyun Ahn, Jong-Joon Ahn, Je Lee, S Kim, Ey Cho, & Wonshik Han. (2011). P2-12-19: Nomogram To Predict Recurrence and To Avoid Unnecessary Adjuvant Chemotherapy Based on Ki67 Index and ER Status in Hormone Receptor (HR)-Positive Breast Cancers with Low Number of Nodal Metastases (≤3) (NCT01273415). Cancer Research, 71, P2-12. https://doi.org/10.1158/0008-5472.sabcs11-p2-12-19

Chicago

B Keam, Y-H Im, S-A Im, Young-Ae Park, SJ Nam, JH Yang, IH Park, et al. 2011. “P2-12-19: Nomogram To Predict Recurrence and To Avoid Unnecessary Adjuvant Chemotherapy Based on Ki67 Index and ER Status in Hormone Receptor (HR)-Positive Breast Cancers with Low Number of Nodal Metastases (≤3) (NCT01273415).” Cancer Research 71 (December): P2-12. doi:10.1158/0008-5472.sabcs11-p2-12-19.